TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer. [electronic resource]
Producer: 20210309Description: 92 p. digitalISSN:- 2041-4889
- Animals
- Antibiotics, Antineoplastic -- chemistry
- Antigens, CD -- genetics
- Apoferritins -- chemistry
- Biomarkers, Tumor -- genetics
- Cell Line, Tumor
- Doxorubicin -- chemistry
- Drug Carriers
- Drug Compounding
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Male
- Mice, Inbred NOD
- Mice, SCID
- Middle Aged
- Nanoparticles
- Neoplasm Transplantation
- Receptors, Transferrin -- genetics
- Signal Transduction
- Stomach Neoplasms -- drug therapy
- Theranostic Nanomedicine
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.